These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17910915)

  • 21. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain.
    Deur C; Agrawal AK; Baum H; Booth J; Bove S; Brieland J; Bunker A; Connolly C; Cornicelli J; Dumin J; Finzel B; Gan X; Guppy S; Kamilar G; Kilgore K; Lee P; Loi CM; Lou Z; Morris M; Philippe L; Przybranowski S; Riley F; Samas B; Sanchez B; Tecle H; Wang Z; Welch K; Wilson M; Yates K
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4599-603. PubMed ID: 17562362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.
    Imanishi M; Itou S; Washizuka K; Hamashima H; Nakajima Y; Araki T; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Jul; 51(13):4002-20. PubMed ID: 18553954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squaric acid N-hydroxylamides: synthesis, structure, and properties of vinylogous hydroxamic acid analogues.
    Lim NC; Morton MD; Jenkins HA; Brückner C
    J Org Chem; 2003 Nov; 68(24):9233-41. PubMed ID: 14629141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR.
    Angell RM; Angell TD; Bamborough P; Brown D; Brown M; Buckton JB; Cockerill SG; Edwards CD; Jones KL; Longstaff T; Smee PA; Smith KJ; Somers DO; Walker AL; Willson M
    Bioorg Med Chem Lett; 2008 Jan; 18(1):324-8. PubMed ID: 17981461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model.
    Keenan RM; Lago MA; Miller WH; Ali FE; Cousins RD; Hall LB; Hwang SM; Jakas DR; Kwon C; Louden C; Nguyen TT; Ohlstein EH; Rieman DJ; Ross ST; Samanen JM; Smith BR; Stadel J; Takata DT; Vickery L; Yuan CC; Yue TL
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3171-6. PubMed ID: 9873697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
    Keenan RM; Miller WH; Lago MA; Ali FE; Bondinell WE; Callahan JF; Calvo RR; Cousins RD; Hwang SM; Jakas DR; Ku TW; Kwon C; Nguyen TT; Reader VA; Rieman DJ; Ross ST; Takata DT; Uzinskas IN; Yuan CC; Smith BR
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3165-70. PubMed ID: 9873696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases.
    Xie J; Comeau AB; Seto CT
    Org Lett; 2004 Jan; 6(1):83-6. PubMed ID: 14703356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
    Lee J; Jin MK; Kang SU; Kim SY; Lee J; Shin M; Hwang J; Cho S; Choi YS; Choi HK; Kim SE; Suh YG; Lee YS; Kim YH; Ha HJ; Toth A; Pearce LV; Tran R; Szabo T; Welter JD; Lundberg DJ; Wang Y; Lazar J; Pavlyukovets VA; Morgan MA; Blumberg PM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4143-50. PubMed ID: 15993063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Squaric acid monoamide mannosides as ligands for the bacterial lectin FimH: covalent inhibition or not?
    Grabosch C; Hartmann M; Schmidt-Lassen J; Lindhorst TK
    Chembiochem; 2011 May; 12(7):1066-74. PubMed ID: 21472956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.
    Covel JA; Santora VJ; Smith JM; Hayashi R; Gallardo C; Weinhouse MI; Ibarra JB; Schultz JA; Park DM; Estrada SA; Hofilena BJ; Pulley MD; Smith BM; Ren A; Suarez M; Frazer J; Edwards J; Hauser EK; Lorea J; Semple G; Grottick AJ
    J Med Chem; 2009 Sep; 52(18):5603-11. PubMed ID: 19722526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.
    Xie YF; Lake K; Ligsay K; Komandla M; Sircar I; Nagarajan G; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Dines K; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3367-72. PubMed ID: 17446072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of 5-HT6 receptor ligands based on virtual HTS.
    Tasler S; Kraus J; Wuzik A; Müller O; Aschenbrenner A; Cubero E; Pascual R; Quintana-Ruiz JR; Dordal A; Mercè R; Codony X
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6224-9. PubMed ID: 17892934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
    Imanishi M; Tomishima Y; Itou S; Hamashima H; Nakajima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Mar; 51(6):1925-44. PubMed ID: 18307290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
    Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
    Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha(v)beta(3) Antagonists based on a central thiophene scaffold.
    Peyman A; Scheunemann K; Will DW; Knolle J; Wehner V; Breipohl G; Stilz HU; Carniato D; Ruxer J; Gourvest J; Auberval M; Doucet B; Baron R; Gaillard M; Gadek TR; Bodary S
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2011-5. PubMed ID: 11454469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
    Angell R; Aston NM; Bamborough P; Buckton JB; Cockerill S; deBoeck SJ; Edwards CD; Holmes DS; Jones KL; Laine DI; Patel S; Smee PA; Smith KJ; Somers DO; Walker AL
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4428-32. PubMed ID: 18614366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structures and spectroscopic properties of ester amide and diamide of squaric acid with prolinamide.
    Kolev T; Seidel RW; Mayer-Figge H; Spiteller M; Sheldrick WS; Koleva BB
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Apr; 72(3):502-9. PubMed ID: 19101193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists.
    Merritt JR; Rokosz LL; Nelson KH; Kaiser B; Wang W; Stauffer TM; Ozgur LE; Schilling A; Li G; Baldwin JJ; Taveras AG; Dwyer MP; Chao J
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4107-10. PubMed ID: 16697193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.